Chair of the Board · Editas Medicine, Inc. (EDIT)

Chair, Nominating/Governance Committee

Jessica Hopfield, Ph.D director compensation at Editas Medicine: $146K

Fiscal year 2025 director compensation for Jessica Hopfield, Ph.D at Editas Medicine, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Jessica Hopfield, Ph.D’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Jessica Hopfield, Ph.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Editas Medicine Director Compensation Table · all 3 fiscal years held
In US dollars, as Editas Medicine reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$93,750$0$52,463$0$146,213
FY2024$63,478—$87,825—$151,303
FY2023$73,008—$158,060$0$231,068

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Editas Medicine, Inc. DEF 14A filed April 28, 2026, accession 0001650664-26-000037, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Editas Medicine, Inc. filed document, accession 0001650664-26-000037. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Get the Editas Medicine Board Governance Report

$146,213 Jessica Hopfield, Ph.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Editas Medicine pays directors a $40,000 cash retainer and $300,000 in Stock Options.

Committees

FY2025 · as the proxy prints them

Audit · Nominating/Governance (Chair)

The rest of the Editas Medicine board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Andrew HirschIndependent Director$118,713
Bernadette ConnaughtonIndependent Director$112,463
David T. Scadden, M.DIndependent Director$99,963
Elliott Levy, M.DIndependent Director$101,213
Gilmore O'Neill, M.B., M.M.ScDirector—

The full Editas Medicine compensation record

free company brief

This page is one director within Editas Medicine's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Editas Medicine proxy · each links to its own free brief

Order EDIT

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report